title: Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies.
authors.affiliation: Safety Promotion and Injury Prevention Research Center, Department of Clinical Epidemiology, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran, s.sabour@sbmu.ac.ir.
authors.forename: Siamak
authors.initials: S
authors.lastname: Sabour
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced*; D005076:Exanthema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008954:Models, Biological